MANFREDI, FRANCESCO
 Distribuzione geografica
Continente #
EU - Europa 142
AS - Asia 114
NA - Nord America 55
SA - Sud America 18
Totale 329
Nazione #
IT - Italia 73
US - Stati Uniti d'America 49
CN - Cina 32
HK - Hong Kong 32
SG - Singapore 32
SE - Svezia 21
BR - Brasile 17
DE - Germania 14
AT - Austria 7
NL - Olanda 7
RU - Federazione Russa 6
CA - Canada 5
FI - Finlandia 5
JP - Giappone 4
BE - Belgio 3
IL - Israele 3
UZ - Uzbekistan 3
CH - Svizzera 2
IE - Irlanda 2
IN - India 2
IR - Iran 2
TW - Taiwan 2
BD - Bangladesh 1
DO - Repubblica Dominicana 1
ES - Italia 1
GB - Regno Unito 1
PE - Perù 1
PK - Pakistan 1
Totale 329
Città #
Hong Kong 31
Singapore 22
Milan 20
Shanghai 17
Ashburn 15
Rome 11
Cesano Boscone 7
Nuremberg 7
Moscow 5
Vienna 5
Bergamo 4
Lawrence 4
Ottawa 4
Princeton 4
Brussels 3
Cantù 3
Ibaraki 3
Kfar Saba 3
Monza 3
Neu-Ulm 3
Tashkent 3
Amsterdam 2
Basel 2
Beijing 2
Benxi 2
Boardman 2
Brescia 2
Burolo 2
Chaoyang 2
Dublin 2
Falkenstein 2
Guangzhou 2
Helsinki 2
New Taipei City 2
New York 2
North Bergen 2
Pune 2
Romagnano Sesia 2
Trento 2
Turku 2
Washington 2
Araraquara 1
Blumenau 1
Brāhmanbāria 1
Cabo Frio 1
Central 1
Cusco 1
Cândido Mota 1
Hidrolândia 1
Ikoma 1
Iracemápolis 1
Jiaxing 1
Juiz de Fora 1
Kashan 1
Lahore 1
Lappeenranta 1
London 1
Morada Nova de Minas 1
Munich 1
Paulínia 1
Piracicaba 1
Recife 1
Resende 1
Rio Claro 1
Segrate 1
Shenzhen 1
São Gonçalo 1
São José do Rio Preto 1
São Paulo 1
Toronto 1
Verdellino 1
Wuxi 1
Zaragoza 1
Totale 249
Nome #
CRISPR-based gene disruption and integration of high-avidity, WT1-specific T cell receptors improve antitumor T cell function 56
Disrupting N-glycan expression on tumor cells boosts chimeric antigen receptor T cell efficacy against solid malignancies 46
Epithelial ovarian cancer is infiltrated by activated effector T cells co-expressing CD39, PD-1, TIM-3, CD137 and interacting with cancer cells and myeloid cells 36
CAR T cell manufacturing from naive/stem memory T lymphocytes enhances antitumor responses while curtailing cytokine release syndrome 35
NON-GENOMIC ALTERATIONS IN ANTIGEN PRESENTATION AND T CELL COSTIMULATION ARE DISTINCT DRIVERS OF LEUKEMIA IMMUNE ESCAPE AND RELAPSE AFTER HEMATOPOIETIC CELL TRANSPLANTATION 32
Flow cytometry data mining by cytoChain identifies determinants of exhaustion and stemness in TCR-engineered T cells 26
Cytomegalovirus-specific T cells restricted for shared and donor human leukocyte antigens differentially impact on Cytomegalovirus reactivation risk after allogeneichematopoietic stem cell transplantation 25
T-N/SCM Pre-Selection Generates CAR T Cell Products Driving Superior Anti-Tumor Responses While Curtailing Severe CRS 24
TCR Redirected T Cells for Cancer Treatment: Achievements, Hurdles, and Goals 19
HARNESSING CD39 FOR THE TREATMENT OF COLORECTAL CANCER AND LIVER METASTASES BY ENGINEERED T CELLS 16
TIM-3, LAG-3, or 2B4 gene disruptions increase the anti-tumor response of engineered T cells 15
Harnessing CD39 for the Treatment of Colorectal Cancer and Liver Metastases by Engineered T Cells 14
Harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells 11
Totale 355
Categoria #
all - tutte 3.710
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.710


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 1 0 0 0 0 0 0
2021/202222 0 0 0 1 0 0 0 4 8 1 3 5
2022/202349 8 8 5 2 4 6 1 2 6 3 1 3
2023/202453 0 0 4 11 6 8 0 7 2 1 5 9
2024/2025230 12 5 8 9 16 28 53 52 18 25 4 0
Totale 355